Discontinued — last reported Q4 '25

Other

Payments to Acquire Marketable Securities

Year-over-year, this metric declined by 100.0%, from $630.52M to $0.00. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Marketable Securities shows an upward trend with a 154.0% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

An increase suggests the company has significant excess cash and is seeking yield, while a decrease may indicate a need for liquidity or a shift in capital allocation strategy.

Detailed definition

Represents the cash outflow used to purchase investment-grade debt or equity securities that are readily marketable. Thi...

Peer comparison

Commonly reported by large-cap industrial firms as part of their treasury and cash management activities.

Metric ID: cvx_payments_to_acquire_marketable_securities

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$50.29M$99.71M$0.00$0.00$0.00$0.00$292.69M-$1.00K$296.04M$300.00M-$300.00M$999.78M$577.47M$630.52M$276.68M$1.18B$0.00$0.00
QoQ Change+98.3%-100.0%-100.0%>999%+1.3%-200.0%+433.3%-42.2%+9.2%-56.1%+328.2%-100.0%
YoY Change-100.0%-100.0%-202.5%>999%+95.1%+110.2%+192.2%+18.5%-100.0%-100.0%
Range-$300.00M$1.18B
Avg YoY Growth>999%
Median YoY Growth-40.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is Insmed's payments to acquire marketable securities?
Insmed (INSM) reported payments to acquire marketable securities of $0.00 in Q1 2026.
How has Insmed's payments to acquire marketable securities changed year-over-year?
Insmed's payments to acquire marketable securities decreased by 100.0% year-over-year, from $630.52M to $0.00.
What is the long-term trend for Insmed's payments to acquire marketable securities?
Over 4 years (2021 to 2025), Insmed's payments to acquire marketable securities has grown at a 154.0% compound annual growth rate (CAGR), from $50.29M to $2.09B.
What does payments to acquire marketable securities mean?
Cash spent on buying short-term or long-term investment securities.